Evidence map›Paper›PMID 34012653›Full record

ArticleJournal of gastrointestinal oncology2021

Comprehensive transcriptome analysis of colorectal cancer risk of hyperglycemia in humans.

Wenming Feng, Huihui Guo, Hui Gong, Tao Xue, Xiang Wang, Chengwu Tang, Yongqiang Xu, Chuang Dai, Ying Bao, Ting Zhang and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Wenming FengDepartment of Surgery, The First Affiliated Hospital of Huzhou University, Huzhou, China.
Huihui GuoCentral Laboratory, The First Affiliated Hospital of Huzhou University, Huzhou, China.
Hui GongCentral Laboratory, The First Affiliated Hospital of Huzhou University, Huzhou, China.
Tao XueCentral Laboratory, The First Affiliated Hospital of Huzhou University, Huzhou, China.
Xiang WangCentral Laboratory, The First Affiliated Hospital of Huzhou University, Huzhou, China.
Chengwu TangDepartment of Surgery, The First Affiliated Hospital of Huzhou University, Huzhou, China.
Yongqiang XuDepartment of Surgery, The First Affiliated Hospital of Huzhou University, Huzhou, China.
Chuang DaiDepartment of Surgery, The First Affiliated Hospital of Huzhou University, Huzhou, China.
Ying BaoDepartment of Surgery, The First Affiliated Hospital of Huzhou University, Huzhou, China.
Ting ZhangDepartment of Pathology, School of Medicine and Nursing Sciences, Huzhou University, Huzhou Central Hospital, Huzhou, China.
Ge CuiDepartment of Pathology, The First Affiliated Hospital of Huzhou University, Huzhou, China.
Huzhou University · CNHuzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEpidemiological studies have found that hyperglycemia, is an independent risk factor for colorectal cancer (CRC), increasing colon cancer incidence and affecting the recurrence, metastasis, and prognosis in colon cancer patients. However, the intercorrelation between hyperglycemia and CRC risk is still unknown, In the present study, we sought to determine whether gene markers, which act in CRC with hyperglycemia, are silenced in CRC without hyperglycemia.

methodsIn order to characterize the mechanism of functional genes associated with CRC with hyperglycemia, A total 24 CRC and matched controls were sequenced. Through bioinformatics analysis includes differential expression analysis, functional enrichment, new isoform prediction and alternative splicing event identification to found biomarker genes related to CRC development.

resultsCRC patients with hyperglycemia were compared with patients without hyperglycemia, and we found that 21 genes were upregulated and 27 were downregulated. Further study showed that these genes are possibly of key genes involved in CRC development with hyperglycemia, such as mannan-binding lectin-associated serine protease 3 (MASP3), which has an immunological role in the activation of the complement system. Based on our comprehensive analysis, a cis-regulatory network for hyperglycemic CRC was reconstructed.

conclusionsProtein-protein interactions revealed the mechanisms of molecules involved in the interaction of hyperglycemia and cancer development. Our results provide further information on the metabolic pathway interaction with cancer pathways and elucidated the mechanisms of hyperglycemic factors function in cancer development from a transcriptomic perspective.

Indexed as

colorectal cancer (CRC)hyperglycemiaTranscriptome

Identifiers

PMID34012653
PMCPMC8107623
OpenAlexW3157994885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.